Bio-Rad Laboratories Basic Shares Outstanding 2010-2025 | BIO
Bio-Rad Laboratories annual/quarterly basic shares outstanding history and growth rate from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- Bio-Rad Laboratories basic shares outstanding for the quarter ending March 31, 2025 were $0.028B, a 2.02% decline year-over-year.
- Bio-Rad Laboratories basic shares outstanding for the twelve months ending March 31, 2025 were $0.112B, a 3.17% decline year-over-year.
- Bio-Rad Laboratories annual basic shares outstanding for 2024 were $0.028B, a 3.41% decline from 2023.
- Bio-Rad Laboratories annual basic shares outstanding for 2023 were $0.029B, a 1.93% decline from 2022.
- Bio-Rad Laboratories annual basic shares outstanding for 2022 were $0.03B, a 0.15% decline from 2021.
| Bio-Rad Laboratories Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $28 |
| 2023 | $29 |
| 2022 | $30 |
| 2021 | $30 |
| 2020 | $30 |
| 2019 | $30 |
| 2018 | $30 |
| 2017 | $30 |
| 2016 | $29 |
| 2015 | $29 |
| 2014 | $29 |
| 2013 | $29 |
| 2012 | $28 |
| 2011 | $28 |
| 2010 | $28 |
| 2009 | $27 |
| Bio-Rad Laboratories Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $28 |
| 2024-12-31 | $28 |
| 2024-09-30 | $28 |
| 2024-06-30 | $28 |
| 2024-03-31 | $29 |
| 2023-12-31 | $29 |
| 2023-09-30 | $29 |
| 2023-06-30 | $29 |
| 2023-03-31 | $30 |
| 2022-12-31 | $30 |
| 2022-09-30 | $30 |
| 2022-06-30 | $30 |
| 2022-03-31 | $30 |
| 2021-12-31 | $30 |
| 2021-09-30 | $30 |
| 2021-06-30 | $30 |
| 2021-03-31 | $30 |
| 2020-12-31 | $30 |
| 2020-09-30 | $30 |
| 2020-06-30 | $30 |
| 2020-03-31 | $30 |
| 2019-12-31 | $30 |
| 2019-09-30 | $30 |
| 2019-06-30 | $30 |
| 2019-03-31 | $30 |
| 2018-12-31 | $30 |
| 2018-09-30 | $30 |
| 2018-06-30 | $30 |
| 2018-03-31 | $30 |
| 2017-12-31 | $30 |
| 2017-09-30 | $30 |
| 2017-06-30 | $30 |
| 2017-03-31 | $30 |
| 2016-12-31 | $29 |
| 2016-09-30 | $29 |
| 2016-06-30 | $29 |
| 2016-03-31 | $29 |
| 2015-12-31 | $29 |
| 2015-09-30 | $29 |
| 2015-06-30 | $29 |
| 2015-03-31 | $29 |
| 2014-12-31 | $29 |
| 2014-09-30 | $29 |
| 2014-06-30 | $29 |
| 2014-03-31 | $29 |
| 2013-12-31 | $29 |
| 2013-09-30 | $29 |
| 2013-06-30 | $29 |
| 2013-03-31 | $28 |
| 2012-12-31 | $28 |
| 2012-09-30 | $28 |
| 2012-06-30 | $28 |
| 2012-03-31 | $28 |
| 2011-12-31 | $28 |
| 2011-09-30 | $28 |
| 2011-06-30 | $28 |
| 2011-03-31 | $28 |
| 2010-12-31 | $28 |
| 2010-09-30 | $28 |
| 2010-06-30 | $28 |
| 2010-03-31 | $28 |
| 2009-12-31 | $27 |
| 2009-09-30 | $27 |
| 2009-06-30 | $27 |
| 2009-03-31 | $27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.090B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.441B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.182B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.45 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.325B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| TriSalus Life Sciences (TLSI) | United States | $0.210B | 0.00 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |